Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19
Shama Ahmad, Shajer Manzoor, Sazia Siddiqui, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 384-398
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Chemokines in colon cancer progression
Shengnan Jia, Yingbo Han, Rui Yang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 400-407
Closed Access | Times Cited: 92
Living Leukocyte‐Based Drug Delivery Systems
Yaxin Chen, Duotian Qin, Jianhua Zou, et al.
Advanced Materials (2022) Vol. 35, Iss. 17
Closed Access | Times Cited: 60
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 27
Long non-coding RNAs regulated NF-κB signaling in cancer metastasis: Micromanaging by not so small non-coding RNAs
Shaniya Ahmad, Madiha Abbas, Mohammad Fahad Ullah, et al.
Seminars in Cancer Biology (2021) Vol. 85, pp. 155-163
Open Access | Times Cited: 47
Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
Reem Khaled M.E. Alsayed, Abdul Quaiyoom Khan, Fareed Ahmad, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 697-708
Open Access | Times Cited: 29
Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions
Reem Khaled M.E. Alsayed, Khalid Sultan A. M. Sheikhan, Majid Alam, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 74-83
Open Access | Times Cited: 19
Spray-Dried Nanolipid Powders for Pulmonary Drug Delivery: A Comprehensive Mini Review
Mahmoud H. Abu Elella, Arwa Omar Al Khatib, Hisham Al-Obaidi
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 680-680
Open Access | Times Cited: 5
The MiR-320 Family Is Strongly Downregulated in Patients with COVID-19 Induced Severe Respiratory Failure
Ruth Pia Duecker, Elisabeth Adam, Sarah Wirtz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10351-10351
Open Access | Times Cited: 33
Epigenetic control of inflammation in Atopic Dermatitis
Sabah Akhtar, Reem Khaled M.E. Alsayed, Fareed Ahmad, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 199-207
Open Access | Times Cited: 13
Mediation of association between benzo[a]pyrene exposure and lung cancer risk by plasma microRNAs: A Chinese case-control study
Yang Xiao, Chenliang Liu, Ye Fu, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 271, pp. 115980-115980
Open Access | Times Cited: 4
Multi-axis transformer based U-Net with class balanced ensemble model for lung disease classification using X-ray images
Suresh Maruthai, Tamilvizhi Thanarajan, T. Ramesh, et al.
Journal of X-Ray Science and Technology (2025)
Closed Access
Pathological Interplay of NF-κB and M1 Macrophages in Chronic Inflammatory Lung Diseases
Fadiyah Jadid Alanazi, Abeer Nuwayfi Alruwaili, Nouf Afit Aldhafeeri, et al.
Pathology - Research and Practice (2025) Vol. 269, pp. 155903-155903
Closed Access
miRNAs: The Key Regulator of COVID-19 Disease
Leyla Tahrani Hardin, Nan Xiao
International Journal of Cell Biology (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 20
Epigenetic regulation of immunosuppressive tumor-associated macrophages through dysregulated microRNAs
Aamir Ahmad
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 26-33
Open Access | Times Cited: 24
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
Hao Luo, Jinlu Shan, Hong Zhang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 960-970
Open Access | Times Cited: 16
Polycystic ovary syndrome and related inflammation in radiomics; relationship with patient outcome
Chunyang Zheng, Yuexin Yu, Xue Bai
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 328-333
Closed Access | Times Cited: 9
Epigenetic regulation of pulmonary inflammation
Shama Ahmad, Xiao Lu Zhang, Aftab Ahmad
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 346-354
Closed Access | Times Cited: 9
Lung inflammation perturbation by engineered nanoparticles
Xiaofei Zhou, Weitao Jin, Jing‐Jun Ma
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 9
Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects
Nisha Gulati, Dinesh Kumar Chellappan, Ronan MacLoughlin, et al.
Life Sciences (2021) Vol. 285, pp. 119969-119969
Closed Access | Times Cited: 22
Nanotechnology-Based Therapeutics for Targeting Inflammatory Lung Diseases
Ching‐Yee Loo, Wing‐Hin Lee
Nanomedicine (2022) Vol. 17, Iss. 12, pp. 865-879
Closed Access | Times Cited: 13
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
Mahda Delshad, Mohammad‐Javad Sanaei, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109128-109128
Open Access | Times Cited: 13
Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic Landscape
Mrinal K. Ghosh, Sunny Kumar, Kirat Kumar Ganguly, et al.
Epigenomics (2023) Vol. 15, Iss. 4, pp. 227-248
Open Access | Times Cited: 7
Risk factors for SARS-CoV-2 pneumonia among renal transplant recipients in Beijing Omicron wave
Guangping Li, Jiangtao Wu, Ying‐Zu Huang, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 2
Combining Classic and Novel Neutrophil-Related Biomarkers to Identify Non-Small-Cell Lung Cancer
Yunzhao R. Ren, Qinchuan Wang, Chenyang Xu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 513-513
Open Access | Times Cited: 2
Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma
Sanjit K. Roy, Shivam Srivastava, Caroline McCance, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top